21.79
price down icon4.93%   -1.13
after-market Dopo l'orario di chiusura: 21.13 -0.66 -3.03%
loading

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

pulisher
01:21 AM

Nurix Therapeutics (NASDAQ:NRIX) Shares Gap DownHere's Why - MarketBeat

01:21 AM
pulisher
Nov 17, 2024

Chevron Corp (CVX-N) QuotePress Release - The Globe and Mail

Nov 17, 2024
pulisher
Nov 17, 2024

Occidental Petroleum Corp (OXY-N) QuotePress Release - The Globe and Mail

Nov 17, 2024
pulisher
Nov 17, 2024

Nurix Therapeutics Presents Preclinical Data from Two - GlobeNewswire

Nov 17, 2024
pulisher
Nov 17, 2024

Nurix Reports Strong Preclinical Data for Two Novel Autoimmune Disease Treatments | NRIX Stock News - StockTitan

Nov 17, 2024
pulisher
Nov 15, 2024

Nurix Therapeutics (NASDAQ:NRIX) Shares Down 8.7%Should You Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Redmile Group, LLC Expands Stake in Nurix Therapeutics Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Significant Stake Increase by Baker Bros. Advisors in Nurix Ther - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

WASATCH ADVISORS LP Adjusts Stake in Nurix Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

When the Price of (NRIX) Talks, People Listen - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 13, 2024

Conocophillips (COP-N) QuotePress Release - The Globe and Mail

Nov 13, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Increases Stake in Nurix Therape - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Purchased by International Assets Investment Management LLC - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

ARK Investment Management LLC Has $49.80 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Nurix Therapeutics stock soars to 52-week high of $27.61 By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Morgan Stanley's Strategic Reduction in Nurix Therapeutics Holdi - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Nurix Therapeutics (NASDAQ:NRIX) Hits New 1-Year HighHere's Why - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Nurix Therapeutics stock soars to 52-week high of $27.61 - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Subdued Growth No Barrier To Nurix Therapeutics, Inc. (NASDAQ:NRIX) With Shares Advancing 25% - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Cisco Systems Inc (CSCO-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024
pulisher
Nov 06, 2024

The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts - Benzinga

Nov 06, 2024
pulisher
Nov 06, 2024

Nurix Therapeutics' (NRIX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Nurix therapeutics' chief legal officer sells $82,250 in stock - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

SEC Form 424B5 filed by Nurix Therapeutics Inc. - Quantisnow

Nov 05, 2024
pulisher
Nov 04, 2024

Nurix therapeutics' chief legal officer sells $82,250 in stock By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 03, 2024

(NRIX) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 02, 2024

Nurix therapeutics CFO Hans van Houte sells $86,083 in stock - Investing.com India

Nov 02, 2024
pulisher
Nov 02, 2024

Houte Hans Van Sells 3,546 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Nurix therapeutics CFO Hans van Houte sells $86,083 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Nurix therapeutics chief legal officer sells $139,866 in stock By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Nurix therapeutics chief legal officer sells $139,866 in stock - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

Insider Sale: CFO Houte Van Sells Shares of Nurix Therapeutics I - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Companies Like Nurix Therapeutics (NASDAQ:NRIX) Are In A Position To Invest In Growth - Simply Wall St

Oct 31, 2024
pulisher
Oct 31, 2024

Nurix therapeutics chief legal officer sells shares worth over $101k - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Nurix therapeutics chief legal officer sells shares worth over $101k By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Nurix therapeutics chief scientific officer sells shares worth $83,536 - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Nurix therapeutics CFO Hans van Houte sells $57,554 in stock - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Nurix therapeutics CFO Hans van Houte sells $57,554 in stock By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

Nurix therapeutics chief scientific officer sells shares worth $83,536 By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

Allspring Global Investments Holdings LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Magna International Inc (MG-T) QuotePress Release - The Globe and Mail

Oct 29, 2024
pulisher
Oct 28, 2024

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Nurix Therapeutics stock soars to 52-week high of $26.46 By Investing.com - Investing.com Canada

Oct 26, 2024
pulisher
Oct 26, 2024

Nurix Therapeutics (NASDAQ:NRIX) Now Covered by UBS Group - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year HighShould You Buy? - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Nurix Therapeutics stock soars to 52-week high of $26.46 - Investing.com India

Oct 25, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):